Loading...
ROS as a novel indicator to predict anticancer drug efficacy
BACKGROUND: Mitochondria are considered a primary intracellular site of reactive oxygen species (ROS) generation. Generally, cancer cells with mitochondrial genetic abnormalities (copy number change and mutations) have escalated ROS levels compared to normal cells. Since high levels of ROS can trigg...
Na minha lista:
| Udgivet i: | BMC Cancer |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6916036/ https://ncbi.nlm.nih.gov/pubmed/31842863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6438-y |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|